These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 23296718)
21. In vitro JAK kinase activity and inhibition assays. Babon JJ; Murphy JM Methods Mol Biol; 2013; 967():39-55. PubMed ID: 23296720 [TBL] [Abstract][Full Text] [Related]
22. Immunological detection of phosphorylation. Yao Z; Seger R Curr Protoc Cell Biol; 2001 May; Chapter 14():Unit 14.2. PubMed ID: 18228325 [TBL] [Abstract][Full Text] [Related]
23. Production and crystallization of recombinant JAK proteins. Lucet IS; Bamert R Methods Mol Biol; 2013; 967():275-300. PubMed ID: 23296737 [TBL] [Abstract][Full Text] [Related]
29. Genetic Encoding of Phosphorylated Amino Acids into Proteins. Allen MC; Karplus PA; Mehl RA; Cooley RB Chem Rev; 2024 May; 124(10):6592-6642. PubMed ID: 38691379 [TBL] [Abstract][Full Text] [Related]
30. JAK3 Y841 Autophosphorylation Is Critical for STAT5B Activation, Kinase Domain Stability and Dimer Formation. Rodriguez G; Martinez GS; Negrete OD; Sun S; Guo W; Xie Y; Li L; Xiao C; Ross JA; Kirken RA Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569303 [TBL] [Abstract][Full Text] [Related]
31. JAK1 Pseudokinase V666G Mutant Dominantly Impairs JAK3 Phosphorylation and IL-2 Signaling. Grant AH; Rodriguez AC; Rodriguez Moncivais OJ; Sun S; Li L; Mohl JE; Leung MY; Kirken RA; Rodriguez G Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047778 [TBL] [Abstract][Full Text] [Related]
32. Quadruple and Truncated MEK3 Mutants Identified from Acute Lymphoblastic Leukemia Promote Degradation and Enhance Proliferation. Ayala-Marin YM; Grant AH; Rodriguez G; Kirken RA Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830095 [TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of CrkL S114 induced by common gamma chain cytokines and T-cell receptor signal transduction. Estrada A; Rodriguez AC; Rodriguez G; Grant AH; Ayala-Marin YM; Arrieta AJ; Kirken RA Sci Rep; 2021 Aug; 11(1):16951. PubMed ID: 34417497 [TBL] [Abstract][Full Text] [Related]
34. Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment. Oaxaca DM; Yang-Reid SA; Ross JA; Rodriguez G; Staniswalis JG; Kirken RA Tumour Biol; 2016 Sep; 37(9):12643-12654. PubMed ID: 27444277 [TBL] [Abstract][Full Text] [Related]
35. Determination of the transphosphorylation sites of Jak2 kinase. Matsuda T; Feng J; Witthuhn BA; Sekine Y; Ihle JN Biochem Biophys Res Commun; 2004 Dec; 325(2):586-94. PubMed ID: 15530433 [TBL] [Abstract][Full Text] [Related]
36. Co-immunoprecipitation protocol to investigate cytokine receptor-associated proteins, e.g., Janus kinases or other associated signaling proteins. Haan C; Haan S Methods Mol Biol; 2013; 967():21-38. PubMed ID: 23296719 [TBL] [Abstract][Full Text] [Related]
37. Role of janus kinase-2 in insulin-mediated phosphorylation and inactivation of protein phosphatase-2A and its impact on upstream insulin signalling components. Begum N; Ragolia L Biochem J; 1999 Dec; 344 Pt 3(Pt 3):895-901. PubMed ID: 10585879 [TBL] [Abstract][Full Text] [Related]
38. Jaks and cytokine receptors--an intimate relationship. Haan C; Kreis S; Margue C; Behrmann I Biochem Pharmacol; 2006 Nov; 72(11):1538-46. PubMed ID: 16750817 [TBL] [Abstract][Full Text] [Related]
39. Analysis of Janus tyrosine kinase phosphorylation and activation. Ross JA; Rodriguez G; Kirken RA Methods Mol Biol; 2013; 967():3-20. PubMed ID: 23296718 [TBL] [Abstract][Full Text] [Related]